CRL Covered Call Strategy
CRL (Charles River Laboratories International, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2.
CRL (Charles River Laboratories International, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $13.70B, a beta of 1.38 versus the broader market, a 52-week range of 144.26-287.955, average daily share volume of 886K, a public-listing history dating back to 2000, approximately 19K full-time employees. These structural characteristics shape how CRL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.38 indicates CRL has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on CRL?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
CRL snapshot
As of August 14, 2026, spot at $278.66, ATM IV 40.90%, IV rank 15.91%, expected move 11.73%. The covered call on CRL below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on CRL specifically: CRL IV at 40.90% is on the cheap side of its 1-year range, which means a premium-selling CRL covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 11.73% (roughly $32.67 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRL expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRL should anchor to the underlying notional of $278.66 per share and to the trader's directional view on CRL stock.
CRL covered call setup
The CRL covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRL at $278.66 on that close, the first option leg uses a $290.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRL chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $278.66 | long |
| Sell 1 | Call | $290.00 | $10.00 |
CRL covered call risk and reward
- Net Premium / Debit
- -$26,866.00
- Max Profit (per contract)
- $2,134.00
- Max Loss (per contract)
- -$26,865.00
- Breakeven(s)
- $268.66
- Risk / Reward Ratio
- 0.079
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
CRL covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on CRL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$26,865.00 |
| $61.62 | -77.9% | -$20,703.78 |
| $123.23 | -55.8% | -$14,542.57 |
| $184.85 | -33.7% | -$8,381.35 |
| $246.46 | -11.6% | -$2,220.14 |
| $308.07 | +10.6% | +$2,134.00 |
| $369.68 | +32.7% | +$2,134.00 |
| $431.30 | +54.8% | +$2,134.00 |
| $492.91 | +76.9% | +$2,134.00 |
| $554.52 | +99.0% | +$2,134.00 |
When traders use covered call on CRL
Covered calls on CRL are an income strategy run on existing CRL stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
CRL thesis for this covered call
The market-implied 1-standard-deviation range for CRL extends from approximately $245.99 on the downside to $311.33 on the upside. A CRL covered call collects premium on an existing long CRL position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether CRL will breach that level within the expiration window. Current CRL IV rank near 15.91% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CRL at 40.90%. As a Healthcare name, CRL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRL-specific events.
CRL covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRL alongside the broader basket even when CRL-specific fundamentals are unchanged. Short-premium structures like a covered call on CRL carry tail risk when realized volatility exceeds the implied move; review historical CRL earnings reactions and macro stress periods before sizing. Always rebuild the position from current CRL chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on CRL?
- A covered call on CRL is the covered call strategy applied to CRL (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With CRL stock at $278.66 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed CRL chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CRL covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the CRL covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 40.90%), the computed maximum profit is $2,134.00 per contract and the computed maximum loss is -$26,865.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CRL covered call?
- The breakeven for the CRL covered call priced on this page is roughly $268.66 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CRL market-implied 1-standard-deviation expected move in the same options snapshot is approximately 11.73%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on CRL?
- Covered calls on CRL are an income strategy run on existing CRL stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current CRL implied volatility affect this covered call?
- CRL ATM IV is at 40.90% with IV rank near 15.91%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.